September 22, 2017 11:50 AM ET

Pharmaceuticals

Company Overview of BioDiem Ltd.

Company Overview

BioDiem Limited, a biopharmaceutical company, develops and commercializes vaccines and infectious disease therapies primarily in Australia and India. The company offers Nasovac-S, a seasonal influenza vaccine based on live attenuated influenza virus technology that is used for the production of seasonal and pandemic influenza vaccines. It is also developing SAVINE, a scrambled antigen vaccine technology for use in the design and customization of immune-stimulation proteins that are used in new vaccine design; and BDM-I, an antimicrobial technology for the treatment of fungal disease, and pneumocystosis and tuberculosis infection. The company is based in South Melbourne, Australia.

100 Albert Road

Level 4

South Melbourne, VIC 3205

Australia

Phone:

61 3 9692 7240

Fax:

61 3 9077 9233

Key Executives for BioDiem Ltd.

Chief Executive Officer and Executive Director
Chief Financial Officer and Company Secretary
Age: 52
Compensation as of Fiscal Year 2017.

BioDiem Ltd. Key Developments

BioDiem Ltd. expected to report Fiscal Year 2017 results on September 22, 2017. This event was calculated by Capital IQ (Created on April 13, 2017).

BioDiem Ltd. expected to report Fiscal Year 2017 results on September 22, 2017. This event was calculated by Capital IQ (Created on April 13, 2017).

BioDiem Ltd., Annual General Meeting, Oct 19, 2016

BioDiem Ltd., Annual General Meeting, Oct 19, 2016, at 13:30 AUS Eastern Standard Time. Location: Grant Thornton, Rialto ­ North Tower Level 30, 525 Collins Street Melbourne - 3000 Victoria Australia Agenda: To receive and consider the financial report of the company and the related reports of the Directors and auditors for the year ended 30 June 2016; to approve election of Professor Arthur Kwok Cheung Li as a Director of the company; and to approve re-election of Mr. Hugh Matheson Morgan as a Director of the company.

BioDiem Ltd. Auditor Raises 'Going Concern' Doubt

BioDiem Ltd. filed its Annual on Sep 19, 2016 for the period ending Jun 30, 2016. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Similar Private Companies By Industry

Company Name Region
4G Vaccines Pty Ltd. Asia
Advent Pharmaceuticals Pty Ltd. Asia
AFT Pharmaceuticals Pty Ltd Asia
Anagen Pty Limited Asia
Ascend Biopharmaceuticals Ltd. Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioDiem Ltd., please visit www.biodiem.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.